Abbreviation | Term | Definition |
AMR | Analytical Measurement Range | The range over which an assay can accurately measure analyte concentrations without dilution or concentration steps. |
ASO | Antisense Oligonucleotide | A synthetic oligonucleotide designed to bind a specific nucleic acid sequence and used in therapeutic development. |
BCR | B-Cell Receptor | A receptor found on B cells and commonly referenced in BCR library workflows. |
BHQ | Black Hole Quencher | A non-fluorescent quencher chemistry used in qPCR probes to reduce background fluorescence and improve signal-to-noise ratios. |
BLAST | Basic Local Alignment Search Tool | A bioinformatics tool used to compare nucleotide or protein sequences and assess sequence similarity and specificity. |
BSL | Biosafety Level | A classification system used to define the containment precautions required when handling biological materials. |
BSL 1 | Biosafety Level 1 | The lowest biosafety containment level, used for well-characterised organisms not known to cause disease in healthy adults. |
CAP | College of American Pathologists | An accreditation organisation whose requirements may be supported through QC software documentation, audit trails and reporting. |
CDMO | Contract Development and Manufacturing Organisation | An organisation that provides development and manufacturing services for pharmaceutical and biotechnology products. |
cDNA | Complementary DNA | DNA synthesised from an RNA template through reverse transcription and commonly used in molecular assays. |
CFR | Code of Federal Regulations | The codified collection of U.S. federal regulations, including requirements applicable to diagnostic testing and quality control materials. |
cGMP | Current Good Manufacturing Practice | Manufacturing standards used to ensure product quality and consistency. |
CHIP | Clonal Haematopoiesis of Indeterminate Potential | A biological source of background variation that can affect ctDNA assay performance and low-frequency variant detection. |
circRNA | Circular RNA | A type of RNA with a covalently closed circular structure being investigated for therapeutic applications. |
CLIA | Clinical Laboratory Improvement Amendments | US regulatory requirements governing laboratory testing and quality practices. |
CLSI | Clinical and Laboratory Standards Institute | An organisation that develops standards and guidelines for laboratory testing and diagnostics. |
CNV / CNVs | Copy Number Variation(s) | Genomic alterations involving gains or losses of DNA segments. |
CPG | Controlled Pore Glass | A solid support material used in solid-phase oligonucleotide synthesis, providing a rigid matrix for building oligonucleotide chains. |
Cq | Quantification Cycle | The PCR cycle at which fluorescence exceeds a defined threshold above background signal during qPCR. |
CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats | A genome-editing technology used in gene modification, screening and molecular biology workflows. |
CRM | Certified Reference Material | A reference material with certified property values, measurement uncertainty and traceability used for calibration and method comparison. |
CRO | Contract Research Organisation | An organisation that provides outsourced research and development services to biotechnology, pharmaceutical and life sciences companies. |
ctDNA | Circulating Tumour DNA | Tumour-derived DNA found in blood and used in liquid biopsy testing. |
CV | Coefficient of Variation | A statistical measure of assay precision and variability used in QC monitoring. |
ddPCR | Droplet Digital Polymerase Chain Reaction | A digital PCR method used for accurate nucleic acid quantification. |
ddRAD | Double Digest Restriction-site Associated DNA Sequencing | A restriction enzyme-based genotyping by sequencing approach used for SNP discovery and genome-wide marker generation. |
DMT | Dimethoxytrityl | A protecting group used during oligonucleotide synthesis and removed during synthesis cycles. |
DNA | Deoxyribonucleic Acid | The genetic material analysed in molecular and genomics assays. |
dPCR | Digital Polymerase Chain Reaction | A highly sensitive technology used to quantify DNA or RNA targets. |
dsDNA | Double-Stranded DNA | The standard two-stranded form of DNA detected by dye-based qPCR chemistries. |
DSM | Disease State Materials | Biological materials sourced from individuals with specific disease conditions and used for assay development, validation and diagnostic research. |
eDNA | Environmental DNA | DNA collected from environmental samples and used in sequencing-based ecological and biodiversity studies. |
ELISA | Enzyme-Linked Immunosorbent Assay | An immunoassay technique used to detect and quantify proteins, antibodies or antigens. |
EQA | External Quality Assessment | A quality control process that compares laboratory performance with peer laboratories to provide independent benchmarking of results. |
FDA | Food and Drug Administration | The U.S. regulatory agency responsible for overseeing the safety and effectiveness of medical devices, diagnostics and other healthcare products. |
FFPE | Formalin-Fixed Paraffin-Embedded | A sample preparation format commonly used for tissue-based molecular testing. |
FHA | Filamentous Haemagglutinin | A Bordetella pertussis antigen used in immunoassay development, serological testing and diagnostic assay development. |
FLT3-ITD | FMS-like Tyrosine Kinase 3 Internal Tandem Duplication | A clinically relevant genetic mutation commonly evaluated in myeloid malignancies. |
FRET | Förster Resonance Energy Transfer | A fluorescence-based detection method used in compatible plate readers for KASP assay analysis. |
FTA | Flinders Technology Associates Card | A sample collection card used for storing and transporting biological samples for DNA analysis. |
GBS | Genotyping-by-Sequencing | A sequencing-based genotyping approach used for SNP discovery, marker development and genome-wide analysis. |
GC | Guanine-Cytosine | Refers to the guanine and cytosine nucleotide content of a DNA sequence, which influences melting temperature and assay design. |
GMO | Genetically Modified Organism | An organism whose genetic material has been modified using genetic engineering techniques. |
GMP | Good Manufacturing Practice | A quality management framework used for manufacturing materials intended for diagnostic, therapeutic and commercial applications. |
GS | Genomic Selection | A breeding approach that uses genome-wide marker information to predict breeding value and support selection decisions. |
GWAS | Genome-Wide Association Studies | Studies that analyse genetic variants across genomes to identify associations with specific traits. |
HIV | Human Immunodeficiency Virus | A virus that attacks the immune system and is a common target for diagnostic assay development and testing. |
HPLC | High-Performance Liquid Chromatography | A purification technique used to separate and purify oligonucleotides and other biomolecules. |
HRD | Homologous Recombination Deficiency | A genomic biomarker associated with deficiencies in DNA repair mechanisms. |
HRP | Horseradish Peroxidase | Enzyme commonly used in immunoassay detection systems. |
IAMQC | Intelligent Automated Management of Quality Control | A family of QC informatics solutions including IAMQC Infinity® and IAMQC Peer®. |
InDel | Insertion-Deletion | A type of genetic marker representing a small insertion or deletion within a DNA sequence. |
INDELs | Insertions and Deletions | Genetic variants involving the insertion or deletion of one or more nucleotides. |
IQ/OQ/PQ | Installation Qualification / Operational Qualification / Performance Qualification | Processes used to verify that laboratory instruments meet intended operational requirements. |
IQC | Internal Quality Control | Quality control procedures performed within a laboratory to monitor routine analytical performance using control materials. |
ISO | International Organisation for Standardisation | An international standards body that publishes quality management and manufacturing standards such as ISO 13485. |
IVD | In Vitro Diagnostics | Tests and products used to analyse biological samples outside the human body. |
IVDR | In Vitro Diagnostic Regulation | The European regulatory framework governing in vitro diagnostic medical devices. |
IVT | In Vitro Transcription | A laboratory process used to synthesise RNA molecules from a DNA template. |
KASP™ | Kompetitive Allele Specific PCR | A PCR-based genotyping technology used for bi-allelic discrimination of SNP and InDel markers. |
LDT | Laboratory Developed Test | A diagnostic test that is designed, manufactured and used within a single laboratory. |
LIMS | Laboratory Information Management System | Software used to manage laboratory workflows, samples and results. |
LIS | Laboratory Information System | A software platform used to manage laboratory data and operations. |
LNA™ | Locked Nucleic Acid | A modified nucleic acid chemistry that improves binding affinity, thermal stability and mismatch discrimination in probes. |
LoB | Limit of Blank | The highest measurement result expected when testing a blank sample containing no target analyte or variant. |
LoD | Limit of Detection | The lowest concentration of a target that can be reliably detected by an assay. |
MAb | Monoclonal Antibody | Antibody that recognises a single epitope, often providing high specificity. |
MAS | Marker-Assisted Selection | A breeding strategy that uses genetic markers associated with desirable traits to select breeding candidates. |
MDx | Molecular Diagnostics | Diagnostic testing that analyses DNA, RNA or other molecular markers to detect disease, monitor health status or guide treatment decisions. |
MGB | Minor Groove Binder | A probe modification chemistry used to enhance probe binding and specificity, particularly for SNP detection. |
MRD | Minimal Residual Disease | Residual cancer cells that remain after treatment and may lead to disease recurrence. Also referred to as molecular residual disease. |
mRNA | Messenger RNA | A type of RNA that carries genetic instructions for protein production and is used in therapeutic applications. |
MSDRx | Medical Software Developers Infinity | Informatics software used for calibration verification, statistical analysis and reporting. |
MSI | Microsatellite Instability | A genomic biomarker associated with defects in DNA mismatch repair. |
NAC | Nucleic Acid Chemistry | Reagents and chemistries used in oligonucleotide synthesis and modification. |
NAT | Nucleic Acid Therapeutics | Therapeutic approaches that use nucleic acid-based molecules such as ASOs and siRNA. |
nGBS | Next-Generation Genotyping by Sequencing | A restriction enzyme-based GBS approach used for SNP discovery and genome-wide marker generation. |
NGS | Next-Generation Sequencing | High-throughput sequencing technology used for genomic analysis and clinical diagnostics. |
NIPT | Non-Invasive Prenatal Testing | A screening approach that analyses fetal genetic material from maternal blood samples. |
NPM1 | Nucleophosmin 1 | A gene commonly assessed in myeloid malignancy testing. |
NTC | No-Template Control | A control reaction containing no target nucleic acid, used to detect contamination and verify assay specificity. |
NTRL | Neutralisation Assay Development Kits | Assay development kits used to identify and qualitatively measure neutralising antibodies against SARS-CoV-2 variants. |
OEM | Original Equipment Manufacturer | A business arrangement in which products or components are manufactured for integration, branding or resale by another organisation. |
PAb | Polyclonal Antibody | Heterogeneous population of antibodies capable of binding multiple epitopes. |
PAGE | Polyacrylamide Gel Electrophoresis | A separation and purification method used for nucleic acids and proteins. |
PCR | Polymerase Chain Reaction | A molecular technology used to amplify and detect nucleic acids. |
PT | Proficiency Testing | An external quality assessment process in which laboratories analyse test samples and compare results against peer laboratories or target values. |
PVDF | Polyvinylidene Difluoride | Solid-phase membrane material used in immunoassay applications. |
QA | Quality Assurance | Processes used to ensure the reliability, accuracy and consistency of laboratory testing. |
QC | Quality Control | The monitoring and evaluation of laboratory test performance to ensure reliable results. |
QMT | Quality Management Tools | Tools and systems used to support laboratory quality monitoring, compliance and performance management. |
qPCR | Quantitative Polymerase Chain Reaction | A PCR-based method that measures DNA amplification in real time, enabling target detection and quantification. |
QTL | Quantitative Trait Locus | A genomic region associated with variation in a quantitative trait. |
RM | Reference Material | A characterised material used to assess analytical performance and support validation or monitoring studies. |
RNA | Ribonucleic Acid | A nucleic acid analysed in applications such as RNA fusion testing and sequencing workflows. |
RPC | Reverse-Phase Cartridge | A purification process used to remove impurities and truncated oligonucleotide sequences during manufacturing. |
RUO | Research Use Only | A product designation indicating that a reagent, instrument or assay is intended for research purposes only and not for use in diagnostic procedures. |
rRNA | Ribosomal Ribonucleic Acid | A component of ribosomes commonly used as a target in microbiome and metagenomics sequencing studies, such as 16S rRNA sequencing. |
RSV | Respiratory Syncytial Virus | A respiratory pathogen commonly targeted in diagnostic assay development and respiratory disease testing. |
RT-PCR | Reverse Transcription Polymerase Chain Reaction | A molecular testing method that converts RNA into DNA and amplifies target sequences for detection. |
RT-qPCR | Reverse Transcription Quantitative Polymerase Chain Reaction | A qPCR method that includes a reverse transcription step to convert RNA into cDNA before amplification for RNA analysis and quantification. |
SARS-CoV | Severe Acute Respiratory Syndrome Coronavirus | A coronavirus targeted by diagnostic reagents and assay development workflows. |
SDS | Safety Data Sheet | A document that provides information on the safe handling, storage and use of chemical or biological products. |
shRNA | Short Hairpin RNA | An RNA molecule used in gene silencing and functional genomics applications. |
siRNA | Small Interfering RNA | A type of RNA molecule used in gene silencing and therapeutic applications. |
SNVs | Single Nucleotide Variants | Genetic alterations affecting a single nucleotide position in DNA. |
SNP | Single Nucleotide Polymorphism | A genetic variation involving a change at a single nucleotide position in the genome and one of the most common marker types used in genotyping and genomic analysis. |
SOP | Standard Operating Procedure | A documented laboratory procedure used to support quality management, consistency and inspection readiness. |
SRM | Standard Reference Material | A certified reference material produced by recognised standards organisations. |
SSR | Simple Sequence Repeat | A DNA marker consisting of short repeated nucleotide sequences used in genetic analysis and breeding applications. |
STI | Sexually Transmitted Infection | An infection primarily transmitted through sexual contact and often detected using diagnostic assays. |
Tm | Melting Temperature | The temperature at which a DNA duplex or probe-target hybrid dissociates and is commonly used for assay and primer design. |
TMB | Tumour Mutational Burden | A measure of the number of mutations present in a tumour genome. |
TMB substrate | Tetramethylbenzidine | Peroxidase substrate commonly used for ELISA signal generation. |
TCR | T-Cell Receptor | A receptor expressed on T lymphocytes that recognises antigen-derived peptides and is commonly analysed in immune repertoire and TCR sequencing studies. |
TNAC | The Native Antigen Company | An LGC business providing recombinant and native antigens, antibodies and virus-like particles for infectious disease diagnostics and research. |
UDI (Diagnostics) | Unique Device Identifier | A unique identifier assigned to medical devices to support traceability, regulatory compliance and post-market surveillance. |
UDI (NGS) | Unique Dual Index | An NGS indexing strategy that uses a unique combination of two indexes to improve sample identification and reduce sample misassignment. |
UMI | Unique Molecular Identifier | A molecular barcode used in sequencing workflows to support error correction and distinguish true variants from technical artefacts. |
UPLC | Ultra-Performance Liquid Chromatography | A high-resolution analytical technique used for quality control and characterisation of oligonucleotides and other biomolecules. |
VAF | Variant Allele Frequency | The proportion of sequencing reads containing a specific genetic variant relative to the total reads at that position. |
VLP | Virus-like Particle | Non-infectious, replication-defective material that mimics key structural characteristics of a virus while lacking the ability to replicate. |
WES | Whole-Exome Sequencing | A sequencing approach that targets the protein-coding regions of the genome to identify genetic variants associated with disease or other biological traits. |
WGS | Whole-Genome Sequencing | A sequencing approach that analyses the complete genomic DNA sequence of an organism, enabling comprehensive detection of genetic variation across the genome. |
:quality(75))